Evidence map›Paper›PMID 25248645›Full record

ArticleNanoscale2014

Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography.

Eric R Swy, Aaron S Schwartz-Duval, Dorela D Shuboni, Matthew T Latourette, Christiane L Mallet, Maciej Parys, David P Cormode, Erik M Shapiro

Abstract read
In one paragraph

Article in Nanoscale, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Ultrasmall Bi/BiNanoscale advances · 2025
    Article
  6. Article
  7. Article
  8. Multifunctional Poly(Acrylic Acid)-Coated EuBiGdInternational journal of nanomedicine · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric R SwyDepartment of Radiology, Michigan State University, East Lansing, MI 48824, USA. erik.shapiro@rad.msu.edu.
Aaron S Schwartz-Duval
Dorela D Shuboni
Matthew T Latourette
Christiane L Mallet
Maciej Parys
David P Cormode
Erik M Shapiro

Funding

Single cell MRI of directed cell migration to strokeDP2OD004362 · OD · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2008 to 2008
$2.5M
Efflux pump inhibitors to reduce duration of antituberculosis therapyDP2OD001886 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI GUMBO, TAWANDA · 2007 to 2007
$2.4M
Theranostic Nanoparticles to enhance morpholino delivery to the liver for suppresR00EB012165 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI CORMODE, DAVID PETER · 2012 to 2014
$706k
MRI Contrast Agents for In vivo Monitoring of Stem Cell DifferentiationR21EB017881 · NIBIB · MICHIGAN STATE UNIVERSITY · PI SHAPIRO, ERIK · 2014 to 2015
$433k
NIBIB NIH HHS R00 EB012165NIBIB NIH HHS R21 EB017881NIH HHS DP2 OD001880NIH HHS DP2 OD001886NIH HHS DP2 OD004362
6 · The paper itself

Abstract

Reports of molecular and cellular imaging using computed tomography (CT) are rapidly increasing. Many of these reports use gold nanoparticles. Bismuth has similar CT contrast properties to gold while being approximately 1000-fold less expensive. Herein we report the design, fabrication, characterization, and CT and fluorescence imaging properties of a novel, dual modality, fluorescent, polymer encapsulated bismuth nanoparticle construct for computed tomography and fluorescence imaging. We also report on cellular internalization and preliminary in vitro and in vivo toxicity effects of these constructs. 40 nm bismuth(0) nanocrystals were synthesized and encapsulated within 120 nm Poly(dl-lactic-co-glycolic acid) (PLGA) nanoparticles by oil-in-water emulsion methodologies. Coumarin-6 was co-encapsulated to impart fluorescence. High encapsulation efficiency was achieved ∼70% bismuth w/w. Particles were shown to internalize within cells following incubation in culture. Bismuth nanocrystals and PLGA encapsulated bismuth nanoparticles exhibited >90% and >70% degradation, respectively, within 24 hours in acidic, lysosomal environment mimicking media and both remained nearly 100% stable in cytosolic/extracellular fluid mimicking media. μCT and clinical CT imaging was performed at multiple X-ray tube voltages to measure concentration dependent attenuation rates as well as to establish the ability to detect the nanoparticles in an ex vivo biological sample. Dual fluorescence and CT imaging is demonstrated as well. In vivo toxicity studies in rats revealed neither clinically apparent side effects nor major alterations in serum chemistry and hematology parameters. Calculations on minimal detection requirements for in vivo targeted imaging using these nanoparticles are presented. Indeed, our results indicate that these nanoparticles may serve as a platform for sensitive and specific targeted molecular CT and fluorescence imaging.

Indexed as

Microscopy, FluorescenceSpectrometry, FluorescenceTomography, X-Ray ComputedAnimalsApoptosisBismuthCell ProliferationCell SurvivalChickensContrast MediaCoumarinsLactic AcidLysosomesMaleMetal NanoparticlesMiceBismuthContrast Mediacoumarin 6CoumarinsLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerThiazoles

Identifiers

PMID25248645
PMCPMC4362618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.